Uncle Sam wants you … to help stop insurers’ bogus Medicare Advantage sales tactics

After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new rules: you.

Bias Capital Cancels $25M Investment in Parker Health Amid Fraud Concerns

What You Should Know: – Bias Capital, an angel syndicate, today announced the cancellation of its $25M Series A investment in healthcare technology company Parker

February 28, 2025

Signal: Nimbus raises $210m to foster drug discovery plans – Pharmaceutical Technology

Nimbus Therapeutics has raised $210m in its latest fundraise. Image Credit: Getty Images/ PM Images Nimbus Therapeutics has closed a $210m fundraising round involving existing

September 7, 2023

California’s Gavin Newsom vetoes bipartisan PBM reform bill

California Gov. Gavin Newsom vetoed bipartisan legislation on Saturday that would have reformed pharmacy benefit managers in the state, prompting the bill’s author to call

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.